These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22276812)

  • 1. Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis.
    Iwashkiw JA; Fentabil MA; Faridmoayer A; Mills DC; Peppler M; Czibener C; Ciocchini AE; Comerci DJ; Ugalde JE; Feldman MF
    Microb Cell Fact; 2012 Jan; 11():13. PubMed ID: 22276812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights from random mutagenesis of Campylobacter jejuni oligosaccharyltransferase PglB.
    Ihssen J; Kowarik M; Wiesli L; Reiss R; Wacker M; Thöny-Meyer L
    BMC Biotechnol; 2012 Sep; 12():67. PubMed ID: 23006740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering.
    Ihssen J; Haas J; Kowarik M; Wiesli L; Wacker M; Schwede T; Thöny-Meyer L
    Open Biol; 2015 Apr; 5(4):140227. PubMed ID: 25833378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.
    Wetter M; Kowarik M; Steffen M; Carranza P; Corradin G; Wacker M
    Glycoconj J; 2013 Jul; 30(5):511-22. PubMed ID: 23053636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bacterial engineered glycoprotein as a novel antigen for diagnosis of bovine brucellosis.
    Ciocchini AE; Serantes DA; Melli LJ; Guidolin LS; Iwashkiw JA; Elena S; Franco C; Nicola AM; Feldman MF; Comerci DJ; Ugalde JE
    Vet Microbiol; 2014 Aug; 172(3-4):455-65. PubMed ID: 24984948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desulfovibrio desulfuricans PglB homolog possesses oligosaccharyltransferase activity with relaxed glycan specificity and distinct protein acceptor sequence requirements.
    Ielmini MV; Feldman MF
    Glycobiology; 2011 Jun; 21(6):734-42. PubMed ID: 21098514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery.
    Garcia-Quintanilla F; Iwashkiw JA; Price NL; Stratilo C; Feldman MF
    Front Microbiol; 2014; 5():381. PubMed ID: 25120536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli.
    Feldman MF; Wacker M; Hernandez M; Hitchen PG; Marolda CL; Kowarik M; Morris HR; Dell A; Valvano MA; Aebi M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):3016-21. PubMed ID: 15703289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins.
    Cuccui J; Wren B
    J Pharm Pharmacol; 2015 Mar; 67(3):338-50. PubMed ID: 25244672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligosaccharyltransferase PglB of Campylobacter jejuni is a glycoprotein.
    Bokhari H; Maryam A; Shahid R; Siddiqi AR
    World J Microbiol Biotechnol; 2019 Dec; 36(1):9. PubMed ID: 31858269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems.
    Wacker M; Feldman MF; Callewaert N; Kowarik M; Clarke BR; Pohl NL; Hernandez M; Vines ED; Valvano MA; Whitfield C; Aebi M
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7088-93. PubMed ID: 16641107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a novel diagnostic test for human brucellosis using a glyco-engineered antigen coupled to magnetic beads.
    Ciocchini AE; Rey Serantes DA; Melli LJ; Iwashkiw JA; Deodato B; Wallach J; Feldman MF; Ugalde JE; Comerci DJ
    PLoS Negl Trop Dis; 2013; 7(2):e2048. PubMed ID: 23459192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered oligosaccharyltransferases with greatly relaxed acceptor-site specificity.
    Ollis AA; Zhang S; Fisher AC; DeLisa MP
    Nat Chem Biol; 2014 Oct; 10(10):816-22. PubMed ID: 25129029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation into the efficiency of diverse N-linking oligosaccharyltransferases for glycoengineering using a standardised cell-free assay.
    Lehri B; Atkins E; Scott TA; Abouelhadid S; Wren BW; Cuccui J
    Microb Biotechnol; 2024 Jun; 17(6):e14480. PubMed ID: 38858807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PglB function and glycosylation efficiency is temperature dependent when the pgl locus is integrated in the Escherichia coli chromosome.
    Terra VS; Mauri M; Sannasiddappa TH; Smith AA; Stevens MP; Grant AJ; Wren BW; Cuccui J;
    Microb Cell Fact; 2022 Jan; 21(1):6. PubMed ID: 34986868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of secretory and extracellular N-linked glycoproteins in Escherichia coli.
    Fisher AC; Haitjema CH; Guarino C; Çelik E; Endicott CE; Reading CA; Merritt JH; Ptak AC; Zhang S; DeLisa MP
    Appl Environ Microbiol; 2011 Feb; 77(3):871-81. PubMed ID: 21131519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of exogenous bacterial oligosaccharyltransferases in Escherichia coli reveals the potential for O-linked protein glycosylation in Vibrio cholerae and Burkholderia thailandensis.
    Gebhart C; Ielmini MV; Reiz B; Price NL; Aas FE; Koomey M; Feldman MF
    Glycobiology; 2012 Jul; 22(7):962-74. PubMed ID: 22391990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing a Cell-Free Glycoprotein Synthesis System for Enzymatic
    DeWinter MA; Wong DA; Fernandez R; Kightlinger W; Thames AH; DeLisa MP; Jewett MC
    ACS Chem Biol; 2024 Jul; 19(7):1570-1582. PubMed ID: 38934647
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of an
    Huang J; Pan C; Sun P; Feng E; Wu J; Zhu L; Wang H
    Microorganisms; 2020 Mar; 8(3):. PubMed ID: 32244903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological crossreactivity between Brucella abortus and Yersinia enterocolitica 0:9 II the use of Yersinia outer proteins for the specific detection of Yersinia enterocolitica infections in ruminants.
    Kittelberger R; Hilbink F; Hansen MF; Ross GP; Joyce MA; Fenwick S; Heesemann J; Wolf-Watz H; Nielsen K
    Vet Microbiol; 1995 Dec; 47(3-4):271-80. PubMed ID: 8748542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.